MIRA vs. BMY

Last updated Jul 14, 2026

MIRA (MIRA Pharmaceuticals Inc. Common Stock) and BMY (Bristol-Myers Squibb Company) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector. Over the past year, MIRA returned -28.93% vs 32.71% for BMY. At a 0.09 correlation, their price movements are largely independent.

Performance

MIRA vs. BMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MIRA Pharmaceuticals Inc. Common Stock (MIRA) and Bristol-Myers Squibb Company (BMY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MIRA achieves a -39.75% return, which is significantly lower than BMY's 13.73% return.

MIRA

• 1D: -1.60%
• 1M: -3.22%
• 6M: -38.53%
• YTD: -39.75%
• 1Y: -28.93%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BMY

• 1D: 3.06%
• 1M: 5.04%
• 6M: 8.71%
• YTD: 13.73%
• 1Y: 32.71%
• 3Y*: 3.33%
• 5Y*: 1.42%
• 10Y*: 1.05%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MIRA vs. BMY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
MIRA MIRA Pharmaceuticals Inc. Common Stock	-39.75%	32.46%	8.57%	-85.00%
BMY Bristol-Myers Squibb Company	13.73%	0.11%	15.81%	-16.06%

Correlation

The correlation between MIRA and BMY is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (All Time) Calculated using the full available price history since Aug 3, 2023	0.09

Fundamentals

Market Cap MIRA : $38.23M BMY : $121.18B
EPS MIRA : -$1.47 BMY : $3.56
Total Revenue (TTM) MIRA : $0.00 BMY : $48.48B
Gross Profit (TTM) MIRA : $0.00 BMY : $33.33B
EBITDA (TTM) MIRA : -$6.93M BMY : $13.34B

Return for Risk

MIRA vs. BMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MIRA

MIRA Risk / Return Rank: 29
MIRA Sharpe Ratio Rank: 29
MIRA Sortino Ratio Rank: 31
MIRA Omega Ratio Rank: 31
MIRA Calmar Ratio Rank: 26
MIRA Martin Ratio Rank: 30

BMY

BMY Risk / Return Rank: 80
BMY Sharpe Ratio Rank: 80
BMY Sortino Ratio Rank: 78
BMY Omega Ratio Rank: 74
BMY Calmar Ratio Rank: 84
BMY Martin Ratio Rank: 82

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MIRA vs. BMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MIRA Pharmaceuticals Inc. Common Stock (MIRA) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MIRA	BMY	Difference
Sharpe ratio: Return per unit of total volatility	-0.37	1.19	-1.56
Sortino ratio: Return per unit of downside risk	-0.12	1.87	-1.99
Omega ratio: Gain probability vs. loss probability	0.99	1.22	-0.23
Calmar ratio: Return relative to maximum drawdown	-0.52	2.62	-3.15
Martin ratio: Return relative to average drawdown	-0.77	5.74	-6.51

MIRA vs. BMY - Sharpe Ratio Comparison

The current MIRA Sharpe Ratio is -0.37, which is lower than the BMY Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of MIRA and BMY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

MIRA vs. BMY - Drawdown Comparison

The maximum MIRA drawdown since its inception was -92.69%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for MIRA and BMY.

Drawdown Indicators

	MIRA	BMY	Difference
Max Drawdown Largest peak-to-trough decline	-92.69%	-72.03%	-20.66%
Max Drawdown (1Y) Largest decline over 1 year	-55.35%	-12.53%	-42.82%
Max Drawdown (3Y) Largest decline over 3 years	—	-36.02%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-47.67%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-47.67%	—
Current Drawdown Current decline from peak	-87.74%	-13.64%	-74.10%
Average Drawdown Average peak-to-trough decline	-78.58%	-22.37%	-56.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.82%	5.71%	+32.11%

Volatility

MIRA vs. BMY - Volatility Comparison

MIRA Pharmaceuticals Inc. Common Stock (MIRA) has a higher volatility of 15.66% compared to Bristol-Myers Squibb Company (BMY) at 9.18%. This indicates that MIRA's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MIRA	BMY	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.66%	9.18%	+6.48%
Volatility (6M) Calculated over the trailing 6-month period	47.25%	18.90%	+28.35%
Volatility (1Y) Calculated over the trailing 1-year period	78.87%	27.70%	+51.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	388.77%	24.33%	+364.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	388.77%	25.40%	+363.37%

Dividends

MIRA vs. BMY - Dividend Comparison

MIRA has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.23%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BMY Bristol-Myers Squibb Company	4.23%	4.60%	4.24%	4.44%	3.00%	2.36%	3.69%	2.55%	3.08%	2.55%	1.95%	2.17%
MIRA MIRA Pharmaceuticals Inc. Common Stock	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both MIRA and BMY in my portfolio?

MIRA and BMY have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MIRA or BMY?

MIRA has higher volatility (15.66%) compared to BMY (9.18%). In terms of maximum drawdown, MIRA dropped -92.69% vs BMY's -72.03%.

Which has better risk-adjusted returns?

BMY currently has the higher Sharpe Ratio (1.19 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.